At Oncode Institute, we believe that meaningful innovation in cancer research happens when world-class science connects with real-world application. For partners in biotech and life sciences - whether industry professionals, entrepreneurs, or investors - collaborating with us offers direct access to pioneering discoveries, entrepreneurial talent, and opportunities to translate research into tangible benefits for patients and society. As cancer remains one of the world’s most complex and urgent health challenges, the path from laboratory insight to patient care depends on robust partnerships. Our collaborative environment means you’ll benefit from: 

• Early access to scientific breakthroughs in cancer biology, tumour modelling, and therapeutic targets.
• Tailored partnership models, whether you seek licensing opportunities, co-development, or strategic alliances.
• An active ecosystem for valorization, supporting entrepreneurship and enabling spin-off creation, co-creation and co-investment opportunities.
• Transparent communication and a shared commitment to advancing science for patient benefit. 

Our track record includes launching new ventures, advancing therapies into clinical trials, and building successful collaborations with a broad range of industry partners. Every partnership is built on trust, scientific excellence, and a shared ambition to improve patient outcomes.